![]() |
|
|
Vol. 302, Issue 1, 18-25, July 2002
in Rheumatoid Synovial Cells
Institute of Medical Science, St. Marianna University School of
Medicine, Kanagawa, Japan (R.Y., N.K., S.K.); and Yakult Central
Institute for Microbiological Research, Tokyo, Japan (R.Y., T.M., S.H.)
Nonsteroidal anti-inflammatory drugs (NSAIDs) have been reported to
induce apoptosis in a variety of cell lines. In this study, we examined
the effect of NSAIDs on the growth and apoptosis of synovial cells from
patients with rheumatoid arthritis and analyzed the activation of
peroxisome proliferator-activated receptor
(PPAR
) as a
possible mechanism of action of NSAIDs. Cell proliferation and
viability were assessed from 5-bromo-2'-deoxyuridine incorporation and
by
4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate (WST-1) assay, respectively. The apoptosis of synovial cells was identified by DNA fragmentation assay and terminal
deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay.
Indometacin, diclofenac, oxaprozin, and zaltoprofen reduced cell
proliferation and induced apoptotic cell death in synovial cells,
whereas ketoprofen and acetaminophen did not.
N-[2-(cyclohexyloxyl)-4-nitrophenyl]-methanesulfonamide (NS-398), a selective cyclooxygenase-2 inhibitor, also
inhibited cell proliferation, whereas it did not cause
apoptosis. Rheumatoid synovial cells expressed PPAR
mRNA, and the
PPAR
ligands 15-deoxy-
12,14-prostaglandin
J2 and troglitazone reduced the proliferation and induced
apoptosis in synovial cells. Luciferase reporter assay demonstrated
that not only PPAR
ligands but also NSAIDs, which could induce
apoptosis, increased the activation of PPAR
in synovial cells.
Furthermore, the ability of NSAIDs and PPAR
ligands to stimulate the
activation of PPAR
correlated with their ability to decrease cell
viability(r = 0.92, p < 0.01) and ability to induce DNA fragmentation
(r = 0.97, p < 0.001) in
synovial cells. These results suggest that PPAR
is an attractive
target for induction of apoptosis in rheumatoid synovial cells and that
the activation of the PPAR
pathway is associated with the apoptotic
action of NSAIDs.
This article has been cited by other articles:
![]() |
T. Haupl, M. Yahyawi, C. Lubke, J. Ringe, T. Rohrlach, G. R. Burmester, M. Sittinger, and C. Kaps Gene Expression Profiling of Rheumatoid Arthritis Synovial Cells Treated with Antirheumatic Drugs J Biomol Screen, April 1, 2007; 12(3): 328 - 340. [Abstract] [PDF] |
||||
![]() |
S. Lev-Ari, L. Strier, D. Kazanov, O. Elkayam, D. Lichtenberg, D. Caspi, and N. Arber Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells Rheumatology, February 1, 2006; 45(2): 171 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lev-Ari, L. Strier, D. Kazanov, L. Madar-Shapiro, H. Dvory-Sobol, I. Pinchuk, B. Marian, D. Lichtenberg, and N. Arber Celecoxib and Curcumin Synergistically Inhibit the Growth of Colorectal Cancer Cells Clin. Cancer Res., September 15, 2005; 11(18): 6738 - 6744. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Morioka, K. Kumagai, K. Morita, S. Kitayama, and T. Dohi Nonsteroidal Anti-Inflammatory Drugs Potentiate 1-Methyl-4-phenylpyridinium (MPP+)-Induced Cell Death by Promoting the Intracellular Accumulation of MPP+ in PC12 Cells J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 800 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Lovering, J. P. Ride, C. M. Bunce, J. C. Desmond, S. M. Cummings, and S. A. White Crystal Structures of Prostaglandin D2 11-Ketoreductase (AKR1C3) in Complex with the Nonsteroidal Anti-Inflammatory Drugs Flufenamic Acid and Indomethacin Cancer Res., March 1, 2004; 64(5): 1802 - 1810. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ando, Y. Murakami, F. Kojima, H. Endo, H. Kitasato, A. Hashimoto, H. Kobayashi, M. Majima, M. Inoue, H. Kondo, et al. Retrovirally Introduced Prostaglandin D2 Synthase Suppresses Lung Injury Induced by Bleomycin Am. J. Respir. Cell Mol. Biol., May 1, 2003; 28(5): 582 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hawcroft, S. H. Gardner, and M. A. Hull Activation of Peroxisome Proliferator-Activated Receptor gamma Does Not Explain the Antiproliferative Activity of the Nonsteroidal Anti-Inflammatory Drug Indomethacin on Human Colorectal Cancer Cells J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 632 - 637. [Abstract] [Full Text] [PDF] |
||||